Technical Analysis for ABMD - ABIOMED, Inc.

Grade Last Price % Change $ Change
grade B $116.89 -0.09% -0.11
ABMD closed down 0.09 percent on Thursday, February 23, 2017, on 67 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ABMD trend table...

Date Alert Name Type % Chg
Feb 23 Upper Bollinger Band Walk Other 0.00%
Feb 23 180 Bullish Setup Bullish Swing Setup 0.00%
Feb 22 NR7 Range Contraction -0.09%
Feb 22 Narrow Range Bar Range Contraction -0.09%
Feb 22 Bearish Engulfing Bearish -0.09%
Feb 22 Stochastic Sell Signal Bearish -0.09%
Feb 22 Upper Bollinger Band Walk Other -0.09%
Feb 17 50 DMA Support Bullish 0.27%
Feb 17 200 DMA Support Bullish 0.27%
Feb 17 Stochastic Reached Overbought Other 0.27%

Older signals for ABMD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.

ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Is ABMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 132.95
52 Week Low 79.62
Average Volume 429,624
200-Day Moving Average 113.48
50-Day Moving Average 112.56
20-Day Moving Average 109.89
10-Day Moving Average 112.66
Average True Range 2.8
ADX 19.46
+DI 30.13
-DI: 21.53
Chandelier Exit (Long, 3 ATRs) 109.76
Chandelier Exit (Short, 3 ATRs) 111.93
Upper Bollinger Band 118.34
Lower Bollinger Band 101.44
Percent B (%b) 0.91
Bandwidth 0.15379